The United States is the global leader in pharmaceutical production, accounting for approximately 45% of worldwide pharmaceutical sales. Valued at over $600 billion as of 2023, the industry is expected to surpass $1 trillion by 2030, driven by innovation, an aging population, and the growing demand for advanced therapies.

The sector contributes about 1.6% to the national GDP and directly employs more than 1.3 million people, while supporting over 4.9 million jobs across the broader economy. The U.S. is home to many of the world’s largest pharmaceutical companies, including Johnson & Johnson, Pfizer, Merck & Co., and AbbVie — all of which invest heavily in research, development, and cutting-edge manufacturing technologies.